Rangeley Capital, LLC Adicet Bio, Inc. Transaction History
Rangeley Capital, LLC
- $116 Billion
- Q3 2025
A detailed history of Rangeley Capital, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Rangeley Capital, LLC holds 75,000 shares of ACET stock, worth $49,500. This represents 0.05% of its overall portfolio holdings.
Number of Shares
75,000Holding current value
$49,500% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding ACET
# of Institutions
58Shares Held
53.3MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA11.4MShares$7.56 Million0.32% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$5.43 Million0.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$4.98 Million0.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$2.48 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$2.16 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $26.4M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...